معرفی
Zhonghua Gao, PhD, serves as Associate Professor in the Department of Molecular and Precision Medicine at Penn State College of Medicine, with active membership in the Penn State Cancer Institute's Next-Generation Therapies scientific program. His work bridges molecular oncology and regenerative medicine through mechanistic studies of stem cell regulation.
Research focuses on epigenetic control of stem cell fate, particularly through Polycomb group proteins (Bmi1, Mel18) and AUTS2-mediated signaling pathways. Key investigations examine Wnt/β-catenin and BMP pathway interactions in hematopoietic stem cell self-renewal and neuronal differentiation, utilizing human cerebral organoid models and hematopoietic systems to uncover mechanisms relevant to cancer and neurodevelopmental disorders.
Publication trends reveal consistent emphasis on transcriptional regulation in stem cell biology, with recent work (2021-2025) demonstrating how epigenetic modifiers like Mel18 repress self-renewal genes while AUTS2 variants dysregulate neurodevelopmental pathways. This molecular precision approach directly informs next-generation therapeutic strategies for malignancies and developmental conditions.
Dr. Gao operates within the Cancer Institute's collaborative ecosystem, contributing to the Next-Generation Therapies program where molecular insights drive translational innovation in precision oncology.
